@Dylan_A_Hester@NoLimitGains Correct -leveraged volume does not indicate upside or downside and is most likely downside which could result in further squeeze - or vice versa
@jimcramer Aren’t you the guy who said to get into NFLX? Moreover aren’t you the guy that disinformation the public with a win rate of less than 10%. Always fade Cramer - how do you sleep at night.
If that were how the system worked, we’d have cured chronic disease decades ago. Insurance and pharma don’t make money by eliminating utilization, they make money by managing it. The model rewards patented drugs, guideline lock-in, long treatment timelines, and predictable billing, not cheap off-patent generics that reduce lifetime spend and hospital throughput. “Saving money” isn’t the incentive - controlling reimbursement pathways and IP is. That’s how managed sick care actually functions.
@Saylorsatsire @ernestomarmo Follow the fibs. We are definitely headed up higher but after a couple retraces to 88 and perhaps 85 with bounces in between. Probably rally tomorrow - Monday before another drop. Who knows how many more surprises they have up there sleeve. Buy the dips.
@elonmusk@boriquagato Soros. $1M via DD for Charity or SWOT team to identify and eradicate bots for non-blue subscribers. Simple algos can cure this problem. If you truly want unmasked and ubiquitous freedom of speech you can’t diminish the efficacy for your broader user base. Margins vs Truth?
@ErikaAwakening It is the only way to impact change - no one is insignificant - some resonate at higher frequencies and thus can make a larger impact on the whole and moreover those that do not, but your question was not congruent with your belie, as it was designed to elicit feedback like this